Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 The Role of Technology Within Regulatory Compliance in Bioanalysis | Contract Pharma

The Role of Technology Within Regulatory Compliance in Bioanalysis

Learn how current technology is playing a role in the regulatory process at PharmSci 360

While the scientific barriers to drug development are a challenge, some wonder about the role AI will play in regulatory practices, especially when considering the future application of Big Data.

Stephanie Pasas-Farmer, Ph.D., BioData Solutions, LLC; Vikram Patal, JD, Ariadne Solutions; and Hao Zhu, Ph.D., U.S. Food and Drug Administration, explain how current technology is playing a role in the regulatory process, and how regulators may view these technology applications.

The session will address:

  • The role of AI within regulatory sciences and submissions
  • AI’s roles in quality standards and a regulatory framework
  • An evidence-based strategy to maximize AI’s benefits when working with the FDA
The Executive Track takes place on Monday, Nov. 4 and Tuesday, Nov 5.

Click here for additional information or to register 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters